A Phase I, Open Label, Fixed Sequence, Single-Center Study to Evaluate the Effect of Multiple Dose Administration of VI-0521 on the Pharmacokinetics of a Single Dose of Oral Contraceptive in Healthy Female Subjects.

Trial Profile

A Phase I, Open Label, Fixed Sequence, Single-Center Study to Evaluate the Effect of Multiple Dose Administration of VI-0521 on the Pharmacokinetics of a Single Dose of Oral Contraceptive in Healthy Female Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs Ethinylestradiol/norethisterone; Phentermine/topiramate
  • Indications Obesity; Pregnancy; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors VIVUS
  • Most Recent Events

    • 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 09 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 9-Mar-2009.
    • 09 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top